Release Date: 04/04/11 08:28 Summary: New Managing Director and CEO Price Sensitive: Yes Download Document 97.67KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%